We are live on
!
Find out more
SCM
Silverarc Capital Management Portfolio holdings
AUM
$849M
1-Year Est. Return
470.8%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$211K
AUM Growth
-$223M
(-100%)
Cap. Flow
+$8.26M
Cap. Flow
% of AUM
3,910.24%
Top 10 Holdings %
Top 10 Hldgs %
55.44%
Holding
84
New
12
Increased
41
Reduced
10
Closed
15
Top Buys
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
+$7.21M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.91M |
| 3 |
Veracyte
VCYT
|
+$5.84M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$4.65M |
| 5 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$3.13M |
Top Sells
| 1 |
RACB
Research Alliance Corp. II Class A Common Stock
RACB
|
+$5.42M |
| 2 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$5.38M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$4.81M |
| 4 |
Halozyme
HALO
|
+$2.85M |
| 5 |
Cytokinetics
CYTK
|
+$2.65M |
Sector Composition
| 1 | Healthcare | 97.67% |
| 2 | Financials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LONA
1
LeonaBio Inc
LONA
$80.1M
| $27K | 12.77% |
+1,000
| New | +$105K |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.9K | 8.95% |
308,819
+113,819
| +58% | +$5.91M |
|
|
SRRA
3
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $14.2K | 6.73% |
443,381
+251,336
| +131% | +$7.21M |
|
|
4
Veracyte
VCYT
$4.75B
| $11.7K | 5.56% |
425,554
+204,192
| +92% | +$5.84M |
|
|
CTIC
5
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $10.5K | 4.98% |
2,250,000
+766,171
| +52% | +$2.29M |
|
|
MRUS
6
DELISTED
Merus
MRUS
| $8.59K | 4.07% |
324,719
+4,545
| +1% | +$122K |
|
7
Cerus
CERS
$637M
| $7.68K | 3.63% |
1,398,400
+355,678
| +34% | +$1.97M |
|
|
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $7.1K | 3.36% |
67,442
+5,742
| +9% | +$560K |
|
|
APEN
9
DELISTED
Apollo Endosurgery, Inc.
APEN
| $6.08K | 2.88% |
1,004,399
+264,795
| +36% | +$1.61M |
|
|
APLS
10
DELISTED
Apellis Pharmaceuticals
APLS
| $5.35K | 2.54% |
+105,368
| New | +$4.65M |
|
11
Aclaris Therapeutics
ACRS
$782M
| $4.75K | 2.25% |
275,333
-10,893
| -4% | -$149K |
|
|
ITOS
12
DELISTED
iTeos Therapeutics
ITOS
| $4.47K | 2.12% |
138,843
+837
| +0.6% | +$30.4K |
|
|
BHVN
13
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.36K | 2.06% |
102,497
+22,149
| +28% | +$2.76M |
|
14
Cogent Biosciences
COGT
$6.72B
| $4.3K | 2.03% |
573,699
-277,236
| -33% | -$1.93M |
|
|
MRTX
15
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.79K | 1.8% |
46,122
-14,635
| -24% | -$1.5M |
|
16
Immatics
IMTX
$1.29B
| $3.56K | 1.68% |
445,334
+54,179
| +14% | +$494K |
|
17
Krystal Biotech
KRYS
$10.3B
| $3.09K | 1.46% |
46,489
-181
| -0.4% | -$11.3K |
|
|
IMGN
18
DELISTED
Immunogen Inc
IMGN
| $3.07K | 1.45% |
645,000
-869,411
| -57% | -$4.81M |
|
|
NGM
19
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.06K | 1.45% |
+200,494
| New | +$3.13M |
|
|
OTIC
20
DELISTED
Otonomy, Inc.
OTIC
| $2.9K | 1.37% |
1,207,385
+7,571
| +0.6% | +$16.1K |
|
|
MORF
21
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.76K | 1.31% |
68,709
+1,269
| +2% | +$53.1K |
|
22
United Therapeutics
UTHR
$22.6B
| $2.66K | 1.26% |
14,836
+285
| +2% | +$54.3K |
|
|
LKFT
23
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $2.54K | 1.2% |
41,002
-87,899
| -68% | -$5.38M |
|
24
Crinetics Pharmaceuticals
CRNX
$8.88B
| $2.5K | 1.18% |
114,004
+2,144
| +2% | +$43.4K |
|
25
Insmed
INSM
$23.8B
| $2.4K | 1.14% |
102,067
+1,446
| +1% | +$33.6K |
|
Similar funds
BOTOTLSJU
LA
EPIMS
CFP
USAA
OMC
AIA
EBSAM